Company intelligence / Profile preview

Digestix Bioscience

Bethesda, Maryland, United Statesdigestix.com ↗
Ownership
Private
Development stage
Other
01

Overview

Digestix Bioscience is in pre-clinical development of an endoscopic medical device and a co-administered pharmaceutical composition designed to locally prevent recurrence of adenomatous colorectal polyps and other early-stage neoplastic local tumors; no clinical results have been reported publicly yet.

Therapeutic areas
OncologyGastroenterology
Modalities
DeviceSmall molecule
Industry
Biotech
02

Partnerships

CNBX Pharmaceuticals (intra-group research services agreement whereby CNBX provides research services to Digestix Bioscience for its development programs)

Beyond the preview

Go deeper on Digestix Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digestix Bioscience.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call